COVID-19: UK government launches public info campaign for Track and Trace, RCN calls for ‘urgent’ release of BAME report, Eli Lilly begins antibody treatment trials, and first UK patients are dosed with bemcentinib in phase II trials.
Interested in Star’s innovative outsourcing and resourcing solutions?
Contact Operations Director, Mark Ward, on 07872 105 540 or email email@example.com.
On the hunt for a new role, or just curious?
Visit our candidate page, submit your CV to firstname.lastname@example.org.
Anyone who tests positive for coronavirus will now be contacted by NHS Test and Trace and asked to share information about their recent interactions.
Eli Lilly has started dosing patients in the world’s first trial for a medicine specifically designed to attack SARS-CoV-2, the virus that causes COVID-19.
The Royal College of Nursing has called for the urgent release of a delayed review into the impact of coronavirus on Black, Asian and minority ethnic communities.
The impact of Covid-19 is also "disproportionate" for other Asian, Caribbean and black ethnicities. But it remains unclear why.
Dosing has commenced in the UK Government-backed Phase II clinical trial assessing BerGenBio's bemcentinib in hospitalised COVID-19 patients.
While you’re here…
…and are interested in our content, why not sign up to our newsletter?
It’s just below.